CYV
Ceryvyn Therapeutics Ltd
$0.0110
0.00%
Market cap
$15M
Turnover
$56,646
Last price
$0.0110
Day change
0.00%
Announcements
2
Range, past year
Open 0.013 · Low 0.008 · Now 0.011 · High 0.014
Open CYV in the full dashboard →
Charts, screener, momentum and signals across every ASX-listed code.
CYV momentum and trend analysis
Our analysis
Independent analysis generated by Stock Trade Intelligence
as at 2026-10-13.
Momentum quality
29/100
Wyckoff phase
Uptrend4d
Trend stage
Emerging
1 Day
+0.0%
1 Week
-8.3%
1 Month
+10.0%
RSI
50
Avg daily range
11.8%
Ceryvyn Therapeutics Ltd scores 29 out of 100 for momentum quality, a reading rated very low confidence. The score weighs trend structure, price consistency, volume backing and how long the move has held, so a high reading means a sustained trend rather than a single large day. Its trend is currently classified as Emerging.
On the Wyckoff cycle it sits in Uptrend, where it has been for 4 trading days. The weekly timeframe reads Distribution, which does not yet agree with the daily view.
Against the wider market it is currently matching and the institutional accumulation signal reads low.
Points to watch
- 60d drawdown -30.8%
- High volatility (ATR 11.8%)
- Thin liquidity
- Risk rating: High
- Composite downside risk elevated
Browse the whole market by signal:
ASX stocks in Wyckoff accumulationASX momentum stocks by trend qualityASX stocks breaking outASX stocks near 52-week highsCYV announcements
Recent price-sensitive releases.
- 2026-08-31 Appendix 4E and 2026 Annual Report Annual Report | Top 20 shareholders | Preliminary Final Report | Full Year Accounts | Full Year Audit Review | Full Year Directors' Statement | Full Year Directors' Report
- 2026-07-27 Quarterly Activities/Appendix 4C Cash Flow Report Commitments Test Entity - Fourth Quarter Activity Report | Commitments Test Entity - Fourth Quarter Cashflow Report
More Health Care stocks
Most traded in the same sector.